Biofilm formation of Streptococcus pneumoniae from bronchial alveolar lavage and from nasal swab by Wróblewska, Joanna et al.
100 www.journals.viamedica.pl/medical_research_journal
ORIGINAL ARTICLE
Joanna Wróblewska1, Agata Białucha1, Emilia Adrianna Kubik2, Eugenia Gospodarek-Komkowska1
1Department of Microbiology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland 
2Student of Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
Biofilm formation of Streptococcus  
pneumoniae from bronchial alveolar 
lavage and from nasal swab
ABSTRACT
Introduction. Infection induced by Streptococcus pneumoniae concerns mainly children, the elderly, and 
people suffering from chronic diseases. The number of deaths caused by pneumococcus infections is 
rising worryingly. The ability to create biofilm is the main virulence factor for S. pneumoniae. The aim of this 
study was to evaluate the ability to form biofilm (using two different dyes) of the bacterial strains isolated 
from nasal and BAL, and evaluate the relationship between antibiotic sensitivity and production of biofilm.
Materials and methods. For the study of S. pneumoniae biofilm formation in 96-well microtitre plates, crystal 
violet (CV) and tetrazolium dyes — 2,3,5-triphenyl-tetrazolium chloride (TTC) were used. 
Results. All isolates were able to form some degree of biofilm. The results obtained by the two methods 
were not significantly correlated when comparing the biofilm mass. The strains produced biofilm mass 
intensive when the dye was CV — 29 (96.6%) strains of S. pneumoniae strong biofilm production. When 
the dye was TTC, it was observed that 14 (46.6%) strains of S. pneumoniae formed strong biofilm. 
Conclusions. There was no significant relationship between the ability of S. pneumoniae to form biofilms 
and the source of isolates. 
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Introduction
Streptococcus pneumoniae commonly colonises 
the nasopharynx asymptomatically in healthy children 
in the first day of life, but colonisation by the pneumo-
coccus may occur at any time during a person’s life [1]. 
This bacteria is the causative agent of several important 
diseases including pneumonia, meningitis, and otitis 
media [2]. Microbial factor, such as enzymes remove 
terminal sugars common to many human glycoconju-
gates, ability to acquire and disseminate resistance to 
multiple antibiotics, polysaccharide capsule, bacterial 
adhesion and biofilm formation, may be responsible for 
growth and survival of S. pneumoniae. Pneumococcal 
cells attaching to host cells provide more opportunities 
for cells for proliferation inside the human body [1]. 
Some diseases caused by this microorganism, such as 
otitis and meningitis, have often been associated with 
the bacteria’s ability to form biofilm [2]. Biofilms, are 
complex communities of bacteria embedded in a ma-
ture matrix composed of extracellular DNA, proteins, 
and polysaccharides [1, 5]. Allegrucci et al. [6] observed 
that biofilm formation of S. pneumoniae occurred in 
several stages: individual planktonic cells attach to the 
surface, later cellular aggregates formed and created, 
and finally the biofilms were fully developed and attained 
maximum cell density (biomass) and height. Biofilm 
development was accompanied by increased produc-
tion of several proteins involved in attachment, such as 
choline binding proteins (CbpA) and pneumococcal 
surface protein A (PspA) [1]. It has been proposed that 
biofilm formation in vivo is intertwined with the formation 
of extracellular neutrophil traps [7].
Biofilm cells are difficult to eradicate with antimicro-
bial treatment, even when the bacterium is susceptible 
to antibiotics in vitro (more resistant to environmental 
stress). In addition, pneumococcal disease treatment 
bring complicated by a greater resistance to antibiotics 
seems to be a characteristic feature of cells that live 
in a sessile state (forming communities) compared to 
cells that adopt a planktonic lifestyle (not attached to 
a surface). Microorganisms in biofilms can be up to 
1000 times more resistant to antibiotics than the same 
free-living microorganisms [2].
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The aim of this study was to evaluate the ability to 
form biofilm (using two different dyes): the bacterial 
strains isolated from nasal and BAL, and to evaluate 
the relationship between antibiotic sensitivity and pro-
duction of biofilm.
Materials and methods
The study included 30 S. pneumoniae strains isolat-
ed the Department of Microbiology of Dr. A. Jurasz Uni-
versity Hospital No 1 in Bydgoszcz, between 2009 and 
2014. S. pneumoniae isolated from clinical samples 
such as bronchoalveolar lavage (BAL) (15 strains) and 
nasal swab (15 strains). The isolates were identified 
by standard microbiological methods, using optiochin 
sensitivity, yellowish/greenish discoloration of 5% sheep 
blood in Tryptic Soy Agar (TSA, Becton-Dickinson) 
plates (blood agar) around bacterial colonies, indicating 
incomplete haemolysis, and latex agglutination test 
(Slidex® pneumo-Kit, bioMérieux). 
Plates were incubated at 37°C, 10% CO2 for 
18 hours. Overnight cultures of each isolate grown 
on blood agar were suspended in Tryptic Soy Broth 
(TSB, BBL) with 1% horse serum (BIOMED) and stan-
dardised to 0.5 McFarland in Tryptic Soy Broth (TSB, 
Becton Dickinson) with a densitometer. Each culture 
was incubated at 37°C, 10% CO2 for 18 hours. The 
resultant cultures were harvested at 4000 RPM (Routs 
Per Minute) for 10 minutes, and washed with sterile, 
deionised water. The precipitate was suspended in 
TSB supplemented with 1% horse serum and stan-
dardised to 0.5 McFarland. 96-well microtitre plates 
(Profilab) were filled with 200 μL of TSB with horse 
serum, which served as negative control (six wells of 
microtitre plate), and 200 μL of inoculum (three wells 
of microtitre plate). Microtitre plates were incubated in 
a humidity chamber at 37°C, 10% CO2. After incuba-
tion the plates were washed three times with sterile, 
deionised water. 
The bacterial cells that had adhered to the surface 
of the polystyrene were fixed by 96% ethanol (POCH) 
for five minutes at room temperature after removal of 
alcohol, the biofilms were stained with 200 μL 2.0% 
crystal violet (CV) for 15 minutes, washed with sterile, 
deionised water, and the plates were left to air dry for 
a further 15 minutes. Finally, 200 μL of 96% ethanol 
was added to each well, and the OD (optical density) 
measured using a microplate reader (Synergy HT, BIO-
TEK) at 570 nm (VC570). 
Bacterial cells adhered to the surface of polysty-
rene were fixed by 100 μL 0.1% TTC and 100 μL TSB. 
Microtitre plates were incubated at 37°C, 10% CO2 for 
two hours, and washed with sterile, deionised water. 
Finally, 200 μL of 96% ethanol was added to each well, 
and the OD was measured using a microplate reader 
(Synergy HT) at 470 nm (TTC470). 
The antibiotic sensitivity test was conducted by disc 
diffusion method (clarithromycin, trimethoprim-sulfame-
thoxazole) and E-test (ampiciline) (bioMérieux) in Muller 
Hinton agar (Becton-Dickinson) containing 5% sheep’s 
blood according to the National Reference Centre for 
Antimicrobial Sensitivity Testing [8]. Statistical signifi-
cance was calculated by the c2 test.
Results
The strains were classified as non-biofilm producers 
(OD ≤ 0.095), weak biofilm producers (0.095 < OD ≤ 0.19), 
moderate biofilm producers (0.19 < OD ≤ 0.38), and 
strong biofilm producers (0.38 > OD) (Al- Martins et al., 
2013). The biofilm formation by tested S. pneumoniae 
strains is presented in Table 1 and 2. 
Results showed that streptococci (all strains tested) 
could form biofilm on the surface of polystyrene. It was 
observed that 14 (46.7%) strains of S. pneumoniae pro-
duced strong biofilm, which five (33.3%) were isolated 
from BAL, and nine (60.0%) were isolated from nasal 
swab. The results proved that 13 (43.3%) strains of 
S. pneumoniae produced moderate biofilm, of which 
nine (60.0%) were isolated from BAL, and four (26.7%) 
were isolated from nasal swab. It was shown that 
three (10.0%) and two (13.3%) species that produced 
the weakest biofilm were isolated from BAL and nasal 
swab, respectively.
In this study, we compared the mass of producing 
biofilms and susceptibility of strains representative of the 
four main classes of antibiotics active against S. pneu-
moniae, namely, ampicilin (for b-lactams), clarithromy-
cin (for macrolides), and trimethoprim/sulphamethoxaz-
ole (for sulphonamide). When assessing the weight of 
the biofilm by means of CV, it was shown that all strains 
isolated from nasal swab resistant to any of the antibiot-
ics listed above produced a strong biofilm. If the weight 
of the biofilm was evaluated using the TTC from five 
ampicillin-resistant strains, then strains 15 and 21 pro-
duced the strong biofilm, and the other three strains 
produced moderate biofilm (strain number: 5, 8, 28). 
Strains 8, 10, 28, and 29, resistant to clarithromycin, 
produced strong biofilm (strain numbers 10 and 29), 
and moderate biofilm (strain number: 8, 28 and 29). 
Only one strain isolated from BAL (strain number 26) 
resistant to trimethoprim/sulphamethoxazole poorly 
produced biofilm. Remaining strains resistant to sul-
phonamide produced strong (strain number: 6, 10, 
23, 29) and moderate biofilm (strain number 5, 26, 28). 
No correlation was seen between the mass produced 
biofilm and resistance to amikacin, clarithromycin, 
trimethoprim/sulphamethoxazole.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
TTC 0.155 0.636 0.380 0.578 0.272 1.069 0.689 0.353 0.166 0.59 0.714 0.677 0.288 1.198 0.717
CV570 0.678 0.643 1.417 1.192 0.759 1.15 1.542 1.02 1.27 0.624 2.917 0.954 1.356 1.754 1.912
Strain no.
BAL 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
TTC 0.255 0.338 0.376 0.668 0.263 0.494 0.376 0.687 0.265 0.296 0.169 0.36 0.204 0.511 0.765
CV570 0.83 0.901 0.692 1.06 0.924 1.347 0.583 1.597 1.059 0.736 0.333 0.73 1.123 0.703 1.21
BAL — bronchoalveolar lavage; TTC — 2,3,5-triphenyl-tetrazolium chloride; CV — crystal violet 




1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Nasal 
swab
TTC WBF SBF MBF SBF MBF SBF SBF MBF WBF SBF SBF SBF MBF SBF SBF
CV570 SBF SBF SBF SBF SBF SBF SBF SBF SBF SBF SBF SBF SBF SBF SBF
Strain no.
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
BAL TTC MBF MBF MBF SBF MBF SBF MBF SBF MBF MBF WBF MBF MBF SBF SBF 
CV570 SBF SBF SBF SBF SBF SBF SBF SBF SBF SBF MBF SBF SBF SBF SBF
BAL — bronchoalveolar lavage; TTC — 2,3,5-triphenyl-tetrazolium chloride; CV — crystal violet; NBF — no biofilm formation; WBF — weak 
biofilm formation; MBF — moderate biofilm formation; SBF — strong biofilm formation
Discussion
S. pneumoniae colonises the human upper respira-
tory tract, and the capacity to form biofilms is believed to 
be important for nasopharyngeal colonisation. Asymp-
tomatic colonisation is known to precede pneumococ-
cal disease, for example community acquired pneumo-
nia, because this bacteria has the ability to migrate to 
other niches within the human body. The presence of 
biofilm-like structures in the lungs of animals infected 
with S. pneumoniae was also documented [9]. During 
infection, S. pneumoniae exists mainly in sessile biofilms 
rather than in planktonic form, except during sepsis [10]. 
Bacteria in diverse niches may be subjected to differ-
ent biotic and abiotic host factors favouring biofilm 
production. The present study evaluated the ability to 
produce the biofilm of S. pneumoniae strains depending 
on clinical origin. 
Camilli et al. [11] using the colorimetric method with 
a dye — Hucker’s crystal violet — demonstrated that five 
strains out of 59 were non-biofilm formers, 16 isolates 
could be classified as weak-biofilm formers, and 38 as 
strong biofilm producers. The OD values adopted in this 
work are slightly different from the values determined in 
our study, and these studies confirm that the majority 
of S. pneumoniae intensively produce biofilm.
The strong biofilm formation percentage was higher 
for the isolation of S. pneumoniae from the nasal vesti-
bule than from the BAL, but not statistically significant 
(p > 0.05). Few authors have evaluated the ability to 
produce the biofilm species isolated from various clin-
ical materials. The aim of the work by García-Castillo 
et al. [12] was to compare the capability for biofilm 
development between S. pneumoniae isolates from 
cystic fibrosis patients and from persons without cystic 
fibrosis, isolated from blood cultures. They observed 
that there were various different capabilities of biofilm 
formation for S. pneumoniae depending on their clinical 
origin. Respectively, 80.0% and 60.0% of blood isolates 
were able to form biofilm. Parker et al. [13], based on 
their own research, support the hypothesis that cells 
induced to form a biofilm have a greater propensity 
to cause pneumonia than planktonic cells. Studies 
by Munoz-Elisa et al. [14] showed that in the case 
of a commensal coloniser such as S. pneumoniae, 
these bacteria produce the virulence factors that are 
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required for colonisation. Thus, strains isolated from 
the nasopharynx will produce biofilm. In contrast, 
studies by Tapianen et al. [15] and Lizcano et al. [16] 
claim that the ability to form biofilms in vitro could not 
be linked to an anatomical site from which a clinical 
isolate was obtained. 
Currently there is no colorimetric standard 
method for investigating the cells in bacterial bio-
films. Tetrazolium salt as TTC, 3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 
2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetra-
zolium-5-carboxanilide (XTT), safranin, and CV are 
examples of dyes used to evaluate the production of 
biofilm. For bacteria, a common method is to quanti-
tate the mass of biofilms by crystal violet or safranin 
staining. Note that when the evaluation of the ability 
of biofilm formation uses CV, the dye is susceptible 
to inaccuracies because it is unable to distinguish 
between living or dead organisms, and CV binds to 
negatively charged molecules, such as nucleic acids 
and acid polysaccharides within the biofilm. TTC is 
reduced to red crystals of 1,3,5-triphenylformazan 
(TFP), which allows for the specific staining of ad-
hered, metabolically active bacteria [17]. In this test 
the biofilm mass was assessed using CV and TTC, 
followed by extraction of bound dye with a solvent 
and measurement of absorption. A significant dif-
ference was demonstrated between in biofilm mass 
and the type of dye used in the study. The strains 
produced intensive biofilm mass when CV was used 
as a dye (p < 0.00001). The data suggests that 
CV gives high levels of nonspecific (false-positive) 
staining. Our results can be compared to studies 
by Sabaeifard et al. [18]. They assessed that the 
biofilm formed in the presence of antibiotics active 
against strains of Pseudomonas aeruginosa, using 
the TTC, XTT, and CV. Their research showed that 
more reproducible and accurate results can be 
obtained using TTC than XTT and CV. In contrast, 
studies by Hendiani et al. [19] showed that CV and 
XTT exhibit an excellent applicability for the quanti-
fication of biofilms of Acinetobacter baumannii, and 
the statistical analysis showed that the results from 
these two methods are significantly correlated. We 
agree with the opinion of these authors that the CV 
assay is cheap, and easy for the quantification of 
biofilms formed by microorganisms, but tetrazolium 
salt is more reliable and repeatable. Different type 
of dye used in the present study significantly affects 
the interpretation produce a biofilm various strains 
of bacteria.
Biofilm structure promotes antibiotic resistance. 
Reduced bacterial susceptibility to antibiotics may be 
associated with metabolic changes accompanying the 
switch from planktonic to sessile lifestyle and horizon-
tal gene transfer due to the high microbial population 
density [20]. S. pneumoniae may be the aetiological 
agent of infection, complications, and death together 
with the emergence of strains resistant to antibiotics. 
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